Glenmark Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

9,925.7

8,619.45

8,473.57

9,213.05

7,976.14

Excise Duty

0

0

0

0

0

Net Sales

9,925.7

8,619.45

8,473.57

9,213.05

7,976.14

Other Operating Income

139.83

130.7

109.15

72.71

107.89

Other Income

102.04

439.78

685.81

59.47

86.27

Total Income

10,167.57

9,189.93

9,268.53

9,345.23

8,170.3

Total Expenditure

8,275.18

8,513.33

7,345.63

7,607.24

6,523.08

PBIDT

1,892.39

676.6

1,922.9

1,737.99

1,647.22

Interest

140.35

367.41

239.9

211.24

269.78

PBDT

1,752.04

309.19

1,683

1,526.75

1,377.44

Depreciation

360.81

430.57

434.16

355.19

332.49

Minority Interest Before NP

0

0

0

0

0

Tax

385.85

57.38

296.47

430.93

390.25

Deferred Tax

-37.37

40.49

171.84

-80.46

-81.51

Reported Profit After Tax

1,042.76

-219.25

780.54

821.08

736.21

Minority Interest After NP

0.31

64.14

54.99

34.96

0.17

Net Profit after Minority Interest

1,042.45

-283.39

725.55

786.13

736.04

Extra-ordinary Items

0

8.7

337.39

-112.77

27.91

Adjusted Profit After Extra-ordinary item

1,042.45

-292.09

388.16

898.9

708.13

EPS (Unit Curr.)

36.94

-10.04

25.71

27.86

26.09

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

28.22

28.22

28.22

28.22

28.22

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.06

7.84

22.69

18.86

20.65

PBDTM(%)

17.65

3.58

19.86

16.57

17.26

PATM(%)

10.5

-2.54

9.21

8.91

9.23